Articles

A veteran money manager shares his top picks.

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

Citrini Research founder James Van Geelen identifies potential big money trends and stakes his claim far ahead of the crowd.

Recently, the stock market has done better on average when the Fed decided to hold rates instead of cut them

The former head of commodities at Bridgewater says current dollar “freakout is overblown.” Own dollar and gold, he advises.

GE Vernova’s stock rallies after an earnings beat and raised outlook amid continued strong demand for electric-grid equipment.

Pinterest and Autodesk are among other tech companies that have started 2026 with layoff announcements.

AT&T added 283,000 fiber subscribers and 421,000 net postpaid phone subscribers in the latest quarter, reflecting a push for “convergence” of connectivity offerings.

There are two opposing views of whether the so-called “sell America” trade is happening.

OpenAI’s latest funding round suggests a valuation of up to $830 billion, while Anthropic’s implies $350 billion

Rarely have two earnings reports so neatly aligned, as microchip equipment maker ASML Holding reported surprisingly strong orders growth as memory-chip producer SK Hynix said it would make a “considerable increase” in capital expenditure.

CFO David Zinsner recently scooped up $250,000 worth of stock, reflecting “belief in Intel and commitment to creating shareholder value.”